Handelsbanken Fonder Ab Fibrogen Inc Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$7.94 - $12.96 $37,318 - $60,912	-4,700 Reduced 20.62%	18,088 $191,000
Q4 2021 Feb 08, 2022	BUY	$9.93 - $15.39 $35,748 - $55,404	3,600 Added 18.76%	22,788 $321,000
Q2 2021 Aug 03, 2021	BUY	$18.57 - $35.68 $66,852 - $128,448	3,600 Added 23.09%	19,188 $511,000
Q1 2021 Apr 29, 2021	SELL	$31.0 - $55.72 $3.29 Million - $5.91 Million	-106,000 Reduced 87.18%	15,588 $541,000
Q3 2020 Nov 13, 2020	BUY	$40.47 - $45.5 $105,222 - $118,300	2,600 Added 2.19%	121,588 $5 Million
Q2 2020 Aug 13, 2020	BUY	$32.57 - $42.83 $1.07 Million - $1.41 Million	32,988 Added 38.36%	118,988 $4.82 Million
Q1 2020 May 14, 2020	BUY	$23.3 - $45.96 $466,000 - $919,200	20,000 Added 30.3%	86,000 $2.99 Million
Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $4.5 Million - $6.25 Million	-130,000 Reduced 66.33%	66,000 $2.83 Million
Q3 2019 Oct 31, 2019	SELL	$36.98 - $48.45 $1.11 Million - $1.45 Million	-30,000 Reduced 13.27%	196,000 $7.25 Million
Q2 2019 Jul 12, 2019	SELL	$35.13 - $55.53 $1.41 Million - $2.22 Million	-40,000 Reduced 15.04%	226,000 $10.2 Million
Q1 2019 May 10, 2019	SELL	$42.83 - $59.91 $3.49 Million - $4.88 Million	-81,400 Reduced 23.43%	266,000 $14.5 Million
Q4 2018 Jan 31, 2019	BUY	$37.97 - $60.16 $5.98 Million - $9.47 Million	157,400 Added 82.84%	347,400 $16.1 Million
Q3 2018 Oct 19, 2018	BUY	$56.3 - $67.25 $1.01 Million - $1.21 Million	18,000 Added 10.47%	190,000 $11.5 Million
Q2 2018 Jul 11, 2018	BUY	$44.9 - $64.95 $269,400 - $389,700	6,000 Added 3.61%	172,000 $10.8 Million
Q1 2018 May 18, 2018	BUY	$45.35 - $61.65 $90,700 - $123,300	2,000 Added 1.22%	166,000 $7.67 Million
Q4 2017 Feb 08, 2018	SELL	$41.95 - $60.1 $1.47 Million - $2.1 Million	-35,000 Reduced 17.59%	164,000 $7.77 Million
Q3 2017 Oct 24, 2017	BUY	$33.4 - $53.9 $6.65 Million - $10.7 Million	199,000	199,000 $10.7 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account